Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer

W.J. van Weelden*, R.I. Lalisang, J. Bulten, K. Lindemann, H.J. van Beekhuizen, H. Trum, D. Boll, H.M.J. Werner, L.R.C.W. van Lonkhuijzen, R. Yigit, D. Forsse, P.O. Witteveen, K. Galaal, A. van Ginkel, E. Bignotti, V. Weinberger, S. Sweegers, J.R. Kroep, S. Cabrera, M.P.L.M. SnijdersM.A. Inda, A.G.Z. Eriksson, C. Krakstad, A. Romano, A. van de Stolpe, J.M.A. Pijnenborg, European Network for Individualized Treatment in Endometrial Cancer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science